Biyanka Patel, Bavarian Nordic, USA

preview_player
Показать описание
Safety and Immunogenicity of an Adjuvanted Chikungunya Virus-like Particle Based Vaccine in Two Pivotal Phase 3 Trials in Persons aged 12-64 and 65 Years of Age
  1. SCON Conferences
  2. #cancer
  3. #vaccines
  4. #conferences
  5. #scon